Literature DB >> 7643716

Effects of doxorubicin on cardiomyocytes with reduced level of superoxide dismutase.

N A Sarvazyan1, A Askari, W H Huang.   

Abstract

Our previous studies have shown that isolated adult rat cardiomyocytes with normal and reduced Cu/Zn SOD activities are equally susceptible to extracellularly generated oxidants (hydrogen peroxide, glucose oxidase/glucose and xanthine oxidase/xanthine systems). In the present study we exposed myocytes with reduced SOD activity to doxorubicin (adriamycin). Cardiotoxicity of doxorubicin has been attributed to the production of superoxide anion inside the cell. Cardiomyocytes with reduced SOD activity, but normal ATP content and viability, were obtained by the treatment of isolated cells with diethyldithiocarbamate (DDC). DDC-treated myocytes were significantly less resistant to doxorubicin than controls. Doxorubicin-stimulated superoxide anion formation, measured by the rate of SOD-inhibitable acetylated cytochrome C reduction, was significantly higher in the cytosolic fraction of DDC-treated cells compared to controls. These results indicate that for isolated cardiac myocytes an essential part of cytotoxicity of doxorubicin can be explained by the formation of superoxide anion and that the level of intracellular SOD activity should be considered as a significant factor for cell protection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643716     DOI: 10.1016/0024-3205(95)02036-i

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase.

Authors:  Michael J Mihm; Fushun Yu; David M Weinstein; Peter J Reiser; John Anthony Bauer
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Molecular biology of doxorubicin-induced cardiomyopathy.

Authors:  J Umlauf; M Horký
Journal:  Exp Clin Cardiol       Date:  2002

3.  Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal.

Authors:  Shulin Xiang; Robert T Dauchy; Adam Hauch; Lulu Mao; Lin Yuan; Melissa A Wren; Victoria P Belancio; Debasis Mondal; Tripp Frasch; David E Blask; Steven M Hill
Journal:  J Pineal Res       Date:  2015-04-20       Impact factor: 13.007

4.  Prevention of doxorubicin-induced cardiotoxicity by melatonin.

Authors:  Eser Oz; Deniz Erbaş; H Selçuk Sürücü; Ersel Düzgün
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 5.  Anthracycline-induced phospholipase A2 inhibition.

Authors:  Luther Swift; Jane McHowat; Narine Sarvazyan
Journal:  Cardiovasc Toxicol       Date:  2007       Impact factor: 3.231

6.  Adriamycin inhibits glycolysis through downregulation of key enzymes in Saccharomyces cerevisiae.

Authors:  Uma Priya Mohan; Selvaraj Kunjiappan; P B Tirupathi Pichiah; Sankarganesh Arunachalam
Journal:  3 Biotech       Date:  2021-01-02       Impact factor: 2.406

7.  Combined effects of p-coumaric acid and naringenin against doxorubicin-induced cardiotoxicity in rats.

Authors:  Shruti S Shiromwar; Vijay R Chidrawar
Journal:  Pharmacognosy Res       Date:  2011-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.